• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.

作者信息

Krowka Michael J

机构信息

Department of Medicine, Division of Pulmonary and Critical Care, Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN.

出版信息

Clin Liver Dis (Hoboken). 2020 Mar 2;15(Suppl 1):S13-S24. doi: 10.1002/cld.846. eCollection 2020 Feb.

DOI:10.1002/cld.846
PMID:32140210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7050952/
Abstract
摘要

相似文献

1
Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.肝肺综合征与门肺高压：肝病的肺血管谜团
Clin Liver Dis (Hoboken). 2020 Mar 2;15(Suppl 1):S13-S24. doi: 10.1002/cld.846. eCollection 2020 Feb.
2
Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome.一名患有既往肝肺综合征的患者在肝移植后出现严重的门肺高压。
J Hepatol. 1999 Dec;31(6):1075-9. doi: 10.1016/s0168-8278(99)80321-3.
3
Pulmonary vascular disorders in portal hypertension.门静脉高压症中的肺血管疾病
Eur Respir J. 1998 May;11(5):1153-66. doi: 10.1183/09031936.98.11051153.
4
Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment.肝肺综合征与门肺高压：发病机制的最新认识及临床评估概述
Liver Int. 2015 Jun;35(6):1646-60. doi: 10.1111/liv.12791. Epub 2015 Feb 16.
5
Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.肝移植后并存门肺高压和肝肺综合征患者对西地那非的反应
Exp Clin Transplant. 2017 Dec;15(6):693-695. doi: 10.6002/ect.2015.0210. Epub 2016 Mar 21.
6
Hepatopulmonary syndrome and portopulmonary hypertension.肝肺综合征和门肺高血压。
Hepatol Res. 2009 Oct;39(10):1020-2. doi: 10.1111/j.1872-034X.2009.00552.x.
7
Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.共存的肝肺综合征和门肺高压：对肝移植的影响。
J Clin Gastroenterol. 2010 Aug;44(7):e136-40. doi: 10.1097/MCG.0b013e3181da76fc.
8
Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era.终末期肝病模型（MELD）时代的肝肺综合征和门肺高压
Liver Transpl. 2004 Oct;10(10 Suppl 2):S54-8. doi: 10.1002/lt.20260.
9
Hepatopulmonary syndrome and portopulmonary hypertension.肝肺综合征与门肺高压
Hosp Pract (1995). 2013 Apr;41(2):62-71. doi: 10.3810/hp.2013.04.1049.
10
Pulmonary Complications of Portal Hypertension.门静脉高压症的肺部并发症。
Clin Liver Dis. 2019 Nov;23(4):683-711. doi: 10.1016/j.cld.2019.06.003. Epub 2019 Aug 9.

引用本文的文献

1
Rare but serious: pulmonary vascular disease around the world.罕见但严重：全球范围内的肺血管疾病
JHLT Open. 2025 Jul 18;9:100327. doi: 10.1016/j.jhlto.2025.100327. eCollection 2025 Aug.
2
Serum proteomics identify biomarkers and pathogenesis of portopulmonary hypertension diagnosed based on echocardiography.血清蛋白质组学鉴定基于超声心动图诊断的门肺高压的生物标志物和发病机制。
Sci Rep. 2025 Jul 1;15(1):21075. doi: 10.1038/s41598-025-08376-6.
3
Cardiac Evaluation in Liver Transplant Candidates.肝移植候选者的心脏评估
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102554. doi: 10.1016/j.jceh.2025.102554. Epub 2025 Mar 27.
4
History of the liver-heart relationship.肝心关系的历史。
Clin Liver Dis (Hoboken). 2024 Apr 26;23(1):e0151. doi: 10.1097/CLD.0000000000000151. eCollection 2024 Jan-Jun.
5
Utility of transesophageal echocardiography during orthotopic liver transplantation: A narrative review.经食管超声心动图在原位肝移植中的应用：一篇叙述性综述。
Ann Card Anaesth. 2023 Oct-Dec;26(4):367-379. doi: 10.4103/aca.aca_186_22.
6
Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertension.人类肝脏单核 RNA 测序提示 BMPR2、GDF15、精氨酸和雌激素与门脉性肺动脉高压有关。
Commun Biol. 2023 Aug 9;6(1):826. doi: 10.1038/s42003-023-05193-3.
7
Hepatopulmonary Syndrome in a Patient With Autoimmune Hepatitis and Chronic Hepatitis C: A Case Report Highlighting Typical Echo Findings.自身免疫性肝炎合并慢性丙型肝炎患者的肝肺综合征：一例突出典型超声表现的病例报告
Cureus. 2023 Jul 7;15(7):e41491. doi: 10.7759/cureus.41491. eCollection 2023 Jul.
8
Cardiac risk stratification of the liver transplant candidate: A comprehensive review.肝移植候选者的心脏风险分层：一项全面综述。
World J Transplant. 2022 Jul 18;12(7):142-156. doi: 10.5500/wjt.v12.i7.142.
9
Pulmonary complications of portal hypertension: The overlooked decompensation.门静脉高压的肺部并发症：被忽视的失代偿情况。
World J Clin Cases. 2022 Jun 16;10(17):5531-5540. doi: 10.12998/wjcc.v10.i17.5531.
10
Pulmonary Hypertension as a Rare Complication After Orthotopic Liver Transplant in a Patient With Non-alcoholic Steatohepatitis (NASH) Cirrhosis Complicated by Hepatopulmonary Syndrome.非酒精性脂肪性肝炎（NASH）肝硬化合并肝肺综合征患者原位肝移植后肺动脉高压作为一种罕见并发症
Cureus. 2022 May 4;14(5):e24740. doi: 10.7759/cureus.24740. eCollection 2022 May.

本文引用的文献

1
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial.马西替坦治疗门脉肺高压（PORTICO）：一项多中心、随机、双盲、安慰剂对照的 4 期临床试验。
Lancet Respir Med. 2019 Jul;7(7):594-604. doi: 10.1016/S2213-2600(19)30091-8. Epub 2019 Jun 6.
2
Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.索拉非尼治疗肝肺综合征：一项随机、双盲、安慰剂对照试验。
Liver Transpl. 2019 Aug;25(8):1155-1164. doi: 10.1002/lt.25438. Epub 2019 May 30.
3
Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experience.肝肺综合征肝移植的结局：欧洲移植组织的经验
Eur Respir J. 2019 Jan 31;53(2). doi: 10.1183/13993003.01096-2018. Print 2019 Feb.
4
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.骨形态发生蛋白 9 是门肺高血压的机制性生物标志物。
Am J Respir Crit Care Med. 2019 Apr 1;199(7):891-902. doi: 10.1164/rccm.201807-1236OC.
5
Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.门脉高压性肺高血压是否会阻碍肝硬化患者的肝移植？一项法国多中心回顾性研究。
Transplantation. 2018 Apr;102(4):616-622. doi: 10.1097/TP.0000000000001981.
6
Predictors of Waitlist Mortality in Portopulmonary Hypertension.门静脉高压性肺动脉高压患者等待名单上死亡的预测因素
Transplantation. 2017 Jul;101(7):1609-1615. doi: 10.1097/TP.0000000000001666.
7
Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.肝移植时平均肺动脉压升高患者的频率及预后
Transplantation. 2017 Jan;101(1):101-106. doi: 10.1097/TP.0000000000001517.
8
Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?门肺高压：肝移植仍应作为合适的考虑对象吗？
Liver Transpl. 2016 Dec;22(12):1637-1642. doi: 10.1002/lt.24625. Epub 2016 Nov 5.
9
International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension.国际肝移植学会实践指南：肝肺综合征和门肺高压的诊断与管理
Transplantation. 2016 Jul;100(7):1440-52. doi: 10.1097/TP.0000000000001229.
10
What's new in the treatment of portopulmonary hypertension?门肺高压治疗方面有哪些新进展？
Expert Rev Gastroenterol Hepatol. 2015 Jul;9(7):983-92. doi: 10.1586/17474124.2015.1035647. Epub 2015 Apr 16.